SK Biopharmaceuticals Selected as One of the "2026 Best Workplaces in Korea"

Selected for Four Consecutive Years and Ranked 23rd Among the Top 100 Companies

President Lee Donghun Named "Most Respected CEO" for the Second Consecutive Year

SK Biopharmaceuticals has been selected as one of the "2026 Best Workplaces in Korea," organized by the global trust management evaluation agency Great Place to Work Institute (GPTW), earning the certification for the fourth consecutive year.

Lee Donghoon, President of SK Biopharm. SK Biopharm

According to SK Biopharmaceuticals on the 25th, the company ranked 23rd in the "100 Best Workplaces in Korea" category. It also received certifications as one of the "Best Workplaces for Parents in Korea" and for "Global ESG Human Rights Management."

In the individual category, President Lee Donghun was selected as one of the "Most Respected CEOs in Korea" for the second consecutive year. Since taking office, he has pursued communication-centered management by sharing key management issues and directly listening to employees' opinions through one-on-one meetings with all employees, departmental roundtable meetings, and regular town hall meetings.

In addition, SK Biopharmaceuticals operates various welfare programs to support work-life balance, including a flexible working system, family care leave, and financial support for children's education.

Lee Donghun, President of SK Biopharmaceuticals, said, "An environment where employees can work with pride and joy is at the core of corporate competitiveness," adding, "We will accelerate our leap forward to become a global big biotech company based on a culture of growing together with our members."